Volume 13, Number 9—September 2007
HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan
|HCV prevalence||107 (36.8)|
|Higher educational level||0.51 (0.29–0.88)|
|Ever shared needle or syringe||2.60 (1.71–3.96)|
|Duration injection drug use >3 y||3.28 (2.17–4.96)|
|Injections by a nonmedical provider||2.71 (1.26–5.82)|
*HCV, hepatitis C virus. Values are no. (%) or adjusted odds ratio (95% confidence interval). Analysis was adjusted for marital status, educational level, duration of injecting, sharing needles or syringes, and injections by a nonmedical provider.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.